FOR US RESIDENTS ONLY

Sanofi Logo

FLUBLOK® QUADRIVALENT—The flu vaccine that is proven to give adults 50+ more protection

In a clinical study of approximately 8,600 people (about 4,300 in each of the 2 groups), FLUBLOK® QUADRIVALENT was proven to be 30% more effective at preventing flu in people 50+ than Fluarix® Quadrivalent (Influenza Vaccine)
In adults 50 years of age and older, the most common side effects were pain and/or tenderness at the injection site, headache, and tiredness
Has 3 times the standard-dose flu shot
Syringe icon showing 30% more effective FLUBLOK® Quadrivalent vaccine in adults 50+
ball

Flu infection poses serious risks at all ages

Even if you’re younger, you can still suffer flu-related complications that can come with the flu. Additionally, you run the risk of passing the flu virus on to vulnerable people around you.


Flu vaccines help reduce the risk of getting the flu and flu-related complications.

Syringe within a location icon
FLU SHOT LOCATOR

What are FLUBLOK® QUADRIVALENT (INFLUENZA VACCINE) and FLUZONE® HIGH-DOSE QUADRIVALENT (INFLUENZA VACCINE)?

Flublok Quadrivalent and Fluzone High-Dose Quadrivalent are indicated for immunization against disease caused by influenza A and B strains contained in the vaccine. Flublok Quadrivalent is given to people 18 years of age and older. Fluzone High-Dose Quadrivalent is given to people 65 years of age and older.

IMPORTANT SAFETY INFORMATION

Flublok Quadrivalent and Fluzone High-Dose Quadrivalent should not be given to anyone who has had a severe allergic reaction to any component of the vaccine (including eggs or egg products for Fluzone High-Dose Quadrivalent). In addition, Fluzone High-Dose Quadrivalent should not be given to anyone who has had a severe allergic reaction after previous dose of any influenza vaccine.

Tell your health care provider if you have ever had Guillain-Barré syndrome (severe muscle weakness) after a previous influenza vaccination.

If Flublok Quadrivalent and Fluzone High-Dose Quadrivalent are given to people with a compromised immune system, including those receiving therapies that suppress the immune system, the immune response may be lower than expected.

Vaccination with Flublok Quadrivalent and Fluzone High-Dose Quadrivalent may not protect all people who receive the vaccine.

For Flublok Quadrivalent, in adults 18 through 49 years of age, the most common side effects were tenderness, and/or pain where you got the shot; headache, tiredness, muscle aches, and joint pain. In adults 50 years of age and older the most common side effects were tenderness, and/or pain where you got the shot; headache, and tiredness.

For Fluzone High-Dose Quadrivalent, in adults 65 years of age and older, the most common side effects were pain, redness, and/or swelling where you got the shot; muscle aches, headache, and general discomfort.

For Flublok Quadrivalent and Fluzone High-Dose Quadrivalent, other side effects may occur.

For more information, talk to your health care professional and refer to the full Prescribing Information for Flublok Quadrivalent or Fluzone High-Dose Quadrivalent. Also, please see complete Patient Information for Fluzone High-Dose Quadrivalent.